Cardiff Oncology Inc
NASDAQ:CRDF
Cardiff Oncology Inc
NASDAQ:CRDF
Price:
1.58
USD
6.76%
Market Closed
Market Cap:
$106.4m
Wall Street
Price Targets
CRDF Price Targets Summary
Cardiff Oncology Inc
Cardiff Oncology Inc
Wall Street analysts forecast CRDF stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
CRDF
is 10.86 USD
with a low forecast of 3.54 USD and a high forecast of 19.95 USD.
Lowest
Price Target
3.54
USD
124% Upside
Average
Price Target
10.86
USD
587% Upside
Highest
Price Target
19.95
USD
1 163% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CRDF's stock price target?
Price Target
10.86
USD
10.86
USD
According to Wall Street analysts, the average 1-year price target for
CRDF
is 10.86 USD
with a low forecast of 3.54 USD and a high forecast of 19.95 USD.
What is Cardiff Oncology Inc's Revenue forecast?
Projected CAGR
-38%
-38%
For the last 13 years the
compound annual growth rate for
Cardiff Oncology Inc's revenue is
8%.
The projected
CAGR
for the next 4 years is
-38%.
